Day and short-term traders have done what they do, and made a very handsome return on it too I would expect.
For those looking for an investment-grade return on business operations rather than simple trading on volatility, I don't see any compelling reason to leap in immediately.
1) FDA approval for our additional claims in the USA will take some months to obtain.
2) Sales of Mente version 2 beginning in August will take some time to roll through into cash flow, and will take even longer to cover the cost of our initial inventory.
Both buy and sell stacks are very thin indeed!
Ann: US Clinical Trial Results Published, page-18
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.6¢ |
Change
-0.003(4.35%) |
Mkt cap ! $64.55M | |||
| Open | High | Low | Value | Volume |
| 6.9¢ | 6.9¢ | 6.6¢ | $59.84K | 904.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 210491 | 6.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.7¢ | 269492 | 3 |
View Market Depth
| Last trade - 14.07pm 25/11/2024 (20 minute delay) ? |
| NTI (ASX) Chart |
